文献速递精神分裂症与精神病性障碍

精神分裂症前额叶与纹状体多巴胺释放呈负相关

Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia.
PubMed 文献 · Biol Psychiatry · 2022-05-14

研究在14例未用药精神分裂症患者和14名健康对照中,用[11C]FLB457和[11C]NPA PET测量皮质与纹状体多巴胺释放。健康对照组[11C]FLB457 ΔBPND高于精神分裂症组(F1,26=5.7;p=.02)。仅精神分裂症组背外侧前额叶[11C]FLB457 ΔBPND与背侧尾状核[11C]NPA ΔBPND呈显著负相关(r=-0.71,p=.005)。

要点

  • 健康对照组皮质[11C]FLB457 ΔBPND高于精神分裂症组(F1,26=5.7;p=.02)。
  • 仅精神分裂症组背外侧前额叶与背侧尾状核多巴胺释放呈显著负相关(r=-0.71,p=.005)。
  • 精神分裂症组显示皮质脑区多巴胺释放缺陷,支持现有多巴胺假说。

核心结论

  • 精神分裂症患者存在皮质脑区多巴胺释放缺陷,且皮质与纹状体多巴胺释放呈负相关,支持现有多巴胺假说。

研究设计与样本

  • 在14例未用药精神分裂症患者和14名健康对照中,于基线和口服0.5 mg/kg d-苯丙胺后测量[11C]FLB457 BPND,并测量纹状体[11C]NPA。

主要发现

  • 健康对照组[11C]FLB457 ΔBPND高于精神分裂症组(F1,26=5.7;p=.02),且皮质脑区差异显著。
  • 仅精神分裂症组背外侧前额叶[11C]FLB457 ΔBPND与背侧尾状核[11C]NPA ΔBPND呈显著负相关(r=-0.71,p=.005)。

关键数值与推荐

  • ΔBPND计算为服药后BPND与基线BPND之差,并以基线BPND百分比表示。
  • 口服d-苯丙胺剂量为0.5 mg/kg。

临床怎么用

  • 在精神分裂症中评估皮质与纹状体多巴胺释放的负相关关系,可为多巴胺假说提供人体在体证据。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The dopamine (DA) hypothesis postulates hyperactivity of subcortical DA transmission and hypoactivity of cortical DA in schizophrenia (SCH). Positron emission tomography provides the ability to assess this hypothesis in humans. However, no studies have examined the relationship between cortical DA and striatal DA in this illness. METHODS: D2/3 receptor radiotracer [11C]FLB457 BPND (binding potential relative to nondisplaceable uptake) was measured in 14 off-medication subjects with SCH and 14 healthy control (HC) subjects at baseline and after the administration of 0.5 mg/kg oral d-amphetamine. The amphetamine-induced change in BPND (ΔBPND) was calculated as the difference between BPND in the postamphetamine condition and BPND in the baseline condition and expressed as a percentage of BPND at baseline. DA release in the striatum using the radiotracer [11C]NPA was also measured in these subjects. RESULTS: [11C]FLB457 ΔBPND was greater in the HC group compared with the SCH group (F1,26 = 5.7; p = .02) with significant differences in [11C]FLB457 ΔBPND seen across cortical brain regions. Only in the SCH group was a significant negative correlation observed between [11C]FLB457 ΔBPND in the dorsolateral prefrontal cortex and [11C]NPA ΔBPND in the dorsal caudate (r = -0.71, p = .005). CONCLUSIONS: Subjects with SCH demonstrated deficits of DA release in cortical brain regions relative to HC subjects. Examining both cortical and striatal DA release in the same subjects demonstrated an inverse relationship between cortical DA release and striatal DA release in SCH not present in HC subjects, providing support for the current DA hypothesis of SCH.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Frankle WG, Himes M, Mason NS, et al. Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia. Biol Psychiatry. 2022. PMID: 35791965. doi:10.1016/j.biopsych.2022.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。